Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort

Abstract

Background: Around a quarter of individuals infected with hepatitis C virus (HCV) are spontaneously able to clear the virus. Correlates of spontaneous HCV clearance are not well established and the aim of this study was to characterize factors associated with spontaneous HCV clearance in a human immunodeficiency virus (HIV)-co-infected cohort. Methods: We analyzed 327 anti-HCV-positive HIV-1-infected patients using multivariate logistic regression. HCV clearance was defined as the presence of anti-HCV with undetectable HCV RNA from at least 2 measurements more than 6 months apart. Results: We included 327 HIV-1-infected individuals, predominantly of Caucasian race; 112 (34%) were females, 258 (79%) were injecting drug users (IDU), 25 (8%) were men who have sex with men (MSM), and 20 (6%) were hepatitis B surface antigen (HBsAg)-positive. Seventy-six (23%; 95% confidence interval (CI) 18–28) had cleared their HCV infection and 251 (77%; 95% CI 72–82) had a chronic infection. The clearance rate in HBsAg-positive individuals was 65%. Being female, HBsAg-positive, or belonging to HIV exposure groups IDU and MSM predicted higher HCV clearance rates (adjusted odds ratio (aOR) 1.8, 95% CI 1–3.2; aOR 7.6, 95% CI 2.7–21; aOR 5.2, 1.2–23.5; and aOR 10.2, 95% CI 1.8–58, respectively). Race, acquired immunodeficiency syndrome (AIDS), and antiretroviral therapy were not associated with HCV clearance. Conclusions: The HCV clearance rate in this HIV-1 cohort was 23%. MSM and IDUs may have higher clearance rates due to their repeated exposure to low-dose HCV, leading to immune memory. Our data suggest an interaction of hepatitis B virus and HCV that influences the outcome of acute HCV infection.

Keywords::

• Hepatitis C virus
• HIV
• hepatitis B virus
• spontaneous HCV clearance
• route of transmission

Acknowledgements

We thank Bodil Landt for expert technical assistance. This study was supported by a PhD stipend from the Faculty of Health Sciences, University of Copenhagen (LNC) and research grants from Preben and Anna Simonsens Foundation (LNC), Danish Medical Research Council (TB), and the A. P. Møller Foundation for the Advancement of Medical Science (TB, NW). Jens Bukh is the recipient of a professorship at the University of Copenhagen with external funding from the Lundbeck Foundation.

Declaration of interest: All authors have no conflicts.